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JC polyomaviruses worldwide are classiﬁed into three super-lineages (A, B and C), with A and B
further split into several lineages and sub-lineages. The transcriptional control region (TCR) of the JCV
genome generally has the archetypal conﬁguration, but rearranged TCRs have occasionally been detected in
isolates from immunocompetent individuals. To investigate the phylogenetic signiﬁcance of these
rearrangements, we analyzed 298 TCR sequences all derived from complete JCV genomes directly cloned
from the urine of non-immunocompromised individuals. While sporadic rearrangements were found in
many lineages and sub-lineages, common rearrangements were identiﬁed in all, or essentially all, isolates
belonging to particular lineages or sub-lineages. Interestingly, several common rearrangements were also
detected as sporadic rearrangements in other lineages or sub-lineages. This observation suggests that during
the course of JCV evolution, JCV strains with sporadic rearrangements became predominant over archetypal
TCRs in some JCV lineages or sub-lineages.
© 2008 Elsevier Inc. All rights reserved.IntroductionJC polyomavirus (JCV) was ﬁrst identiﬁed as the causative agent of
a fatal demyelinating disease in the central nervous system, known as
progressive multifocal leukoencephalopathy (PML) (Padgett et al.,
1971). This virus, however, is ubiquitous in humans, infecting children
asymptomatically then persisting in renal tissues (Chesters et al.,
1983; Padgett andWalker 1973; Tominaga et al., 1992). In most adults,
renal JCV is not latent but replicates to generate progeny in the urine
(Kitamura et al., 1990,1994). JCV is usually transmitted from parents to
offspring during long-term cohabitation (Kunitake et al., 1995; Kato et
al., 1997; Suzuki et al., 2002; Zheng et al., 2004).
All JCV strains are members of a single serotype (Major, 2001).
Nevertheless, based on genetic variations in the genome, JCV strains
worldwide are classiﬁed into three super-lineages (A, B and C)
(Sugimoto et al., 2002a). Super-lineages A and B are subdivided into
several lineages, many of which are further split into multiple sub-
lineages (Supplementary Fig. 1). Each lineage and sub-lineage occupy a
uniquegeographical domain (Yogo et al., 2004) (Table 1), suggesting that
the evolution of JCV occurred in association with human populations.
The genome of JCV is a single molecule of double-stranded,
covalently circular DNA about 5100 bp in length, and consists of early,
late, and regulatory regions (Frisque et al., 1984). The regulatory region
contains the origin of replication and the transcriptional control
region (TCR). Before 1990, JCV strains were isolated mainly from thel rights reserved.brains of PML patients, and TCRs (designated PML-type) of these
strains had been shown to be hypervariable, with deletions and
ampliﬁcations of various segments (Martin et al., 1985; Matsuda et al.,
1987; Loeber and Dörries 1988). However, Yogo et al. (1990) found
that the TCRs of JCV genomes molecularly cloned directly from the
urine of healthy volunteers and non-immunosuppressed patients had
the same basic structure (designated as the archetype), having only a
few nucleotide mismatches. Based on a comparison between arche-
type and PML-type TCRs, it was hypothesized that various TCRs from
the brains of PML patients were produced from the archetype by
deletion and ampliﬁcation, or deletion alone (Yogo et al., 1990; Iida et
al., 1993; Ault and Stoner 1993). JCV strains with archetype TCRs have
been detected not only in the urine of non-immunosuppressed
patients worldwide (Yogo et al., 1991; Guo et al., 1996; Agostini et al.,
1996, 2001; Jeong et al., 2004) but also in renal and tonsillar tissues of
non-PML patients (Tominaga et al., 1992; Kato et al., 2004), and hence
it appears that JCV strains with archetype TCRs circulate in various
human populations (Yogo et al., 2004).
Since the ﬁrst isolation of JCV strains with archetype TCRs from
urine (Yogo et al., 1990), JCV strains with rearranged TCRs have
sometime been detected in the urine of non-immunocompromised
individuals, albeit with low frequencies (Yogo et al., 1990,1991; Guo et
al., 1996; Agostini et al., 1996, 2001; Jeong et al., 2004). Compared to
the complicated rearrangements in PML-type TCRs, these TCRs
showed simple rearrangements (deletions or duplications of short
segments). To investigate the phylogenetic signiﬁcance of these
rearrangements, we analyzed 298 TCR sequences of JCV all derived
from complete viral genomes directly cloned from the urine of non-
Table 1
Summary of the results of the present analysis
Super-lineage Lineagea Sub-lineagea Geographic distribution (ethnic origin) No. of isolates
analyzed
Presence (+) or absence (−)
of common rearrangement
No. (%) of isolates with
sporadic rearrangement
A EU-a EU-a1 (Type 1A) Europe, Mediterranean areas, Japan, Korea,
N.E. Siberia (Chukuchi), Arctic areas (Inuit), USA
25 − 3 (12)
EU-a2 (Type 1B) Europe, USA 13 − 2 (15)
A EU-b (Type 4) Europe, Mediterranean areas, USA 6 − 0 (0)
A EU-cb N.E. Siberia (Nanai), N. Japan (Ainu) 8 − 3 (38)c
C Af1 (Type 6) W. and Central Africa, USA 4 − 2 (50)d
B Af2 Af2-a (Type 3B) S. Africa, USA 6 − 0 (0)
Af2-b (Type 3A) Africa, W. Asia, India 42 − 3 (7)
B B1-a (Type 7C1) China, Philippines 14 − 2 (14)
B B1-b B1-b1 (Type 7D1) Mongolia, W. China, S.W. and Central Asia,
Myanmar
16 + (2-bp del) 0 (0)
B1-b2 (Type 7D2) S. Asia 5 + (2-bp del) 1 (20)
B B1-c (Type 2B) Europe, Mediterranean areas, USA 3 − 0 (0)
B B1-d (Type 2D3) Saudi Arabia 4 + (2-bp del) 0 (0)
B B2 (Type 7C2) India, Nepal, Mauritius 3 − 0 (0)
B B3-a (Type 7B2) China, Philippines, Indonesia 5 − 0 (0)
B CY (Type 7B1) CY-a Japan, Korea, N. China, USA 15 − 2 (13)
B CY-b Japan, Korea, N. China, USA 7 − 1 (14)
B MXb N. Japan (Ainu) 3 − 0 (0)
B MY (Type 2A) MY-a Japan 3 − 0 (0)
MY-b Japan, Korea, USA 10 − 0 (0)
MY-c Mexico, Guatemala, USA (Tarahumalan) 6 + (1-bp del) 0 (0)
MY-e Guatemala, Mexico, USA (Mayan) 6 + (10-bp del) 0 (0)
MY-f Peru (Aymara/Quechua) 5 + (10-bp del) 0 (0)
MY-g Canada (Beaver/Dene Tha') 5 − 3 (60)e
MY-x Japan (Ainu) 1 − 0 (0)
Others Mexico 2 − 0 (0)
B SC (Type 7A) SC-a Thailand 2 − 0 (0)
SC-b Myanmar, Mongolia 2 − 1 (50)f
SC-c Thailand 4 − 1 (25)g
SC-d Myanmar 6 − 0 (0)
SC-e Myanmar 4 − 2 (50)h
SC-f S. China, S.E. Asia, Near Oceania, USA 33 + (5-bp del) 1 (3)
SC-g Kiribati 5 − 0 (0)
SC-x Philippines 6 − 0 (0)
Others Myanmar 1 − 0 (0)
B 2E (Type 2E) 2E/KB Kiribati 10 + (9-bp dup) 0 (0)
Others Island S.E. Asia, Oceania 8 − 1 (13)
Total 298 28 (9)
a Nomenclature by Stoner's group (Cui et al., 2004) is shown within parentheses.
b Corresponding JCV lineages have not been reported by Stoner's group.
c Pb0.01 vs. B1-b1 and SC-f; Pb0.05 vs. Af2-b, MY-b and 2E/KB.
d Pb0.01 vs. Af2-b, B1-b1 and SC-f; Pb0.05 vs. MY-b and 2E/KB.
e Pb0.01 vs. Af2-b, B1-b1, MY-b, SC-f and 2E/KB; Pb0.05 vs. EU-a1,-b, Af2-a, B1-a, B3-a, CY-a, MY-c, -e, -f, SC-d, -g and -x.
f Pb0.01 vs. B1-b1, SC-f; Pb0.05 vs. Af2-b, MY-b, 2E/KB.
g Pb0.05 vs. B1-b1.
h Pb0.01 vs. Af2-b, B1-b1, SC-f; Pb0.05 vs. MY-b and 2E/KB.
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to detect TCR rearrangements but also to unambiguously classify the
JCV strains into lineages and sub-lineages. We discuss the implications
of the obtained results based on a close relationship between JCV
lineages (or sub-lineages) and human populations.
Results
Consensus TCR sequences for respective lineages and sub-lineages
We aligned the TCR sequences belonging to the same lineages or
sub-lineages together with the representative archetypal TCR [i.e., the
TCR of isolate CY (Yogo et al., 1990)]. This alignment identiﬁed not only
consensus TCR sequences among isolates belonging to respective
lineages or sub-lineages but also TCRs having sporadic rearrange-
ments found only in one of a few isolates of the lineages or sub-
lineages (the features of the sporadic rearrangements will be
described in the next section).
The consensus TCRs of most JCV lineages and sub-lineages were
archetypal, that is, identical, or almost identical, with the CY TCR, with
a few nucleotide mismatches but without any rearrangements(deletions or duplications) (Fig. 1). These lineages and sub-lineages
included all lineages (EU-a, -b and -c) belonging to the super-lineage
A, ﬁve lineages (Af2, B1-a, -c, B2, B3-a and CY) belonging to super-
lineage B, the single lineage (Af1) belonging to super-lineage C, and
most sub-lineages of lineages MY, SC and 2E.
However, two lineages (B1-b and -d), threeMY sub-lineages (MY-c,
-e and -f), one SC sub-lineage (SC-f), and one 2E sub-lineage (2E/KB)
had TCRs that deviated from the archetypal TCR by deletion or
duplication (these rearrangements were designated as common TCR
rearrangements) (Fig. 1 and Table 1). In B1-b1, -b2 and -d, a 2-bp
segment spanning nucleotides (nt) 217 to 218 (nucleotide positions
will be expressed as those of isolate CY; GenBank/EMBL/DDBJ
accession number, AB038249) was deleted; in MY-c, a single nucleo-
tide (nt 223) was deleted; in SC-f, a 5-bp segment (nt 218–222) was
deleted; and in 2E/KB, a 9-bp segment (nt 91–99) was duplicated.
Sporadic TCR rearrangements
Although sporadic TCR rearrangements were not detected in
lineages, except for Af1, for which only a small number of isolates were
examined, they occurred in ten lineages belonging to the three super-
Fig. 1. TCR sequences detected in various JCV lineages and sub-lineages. Sequences between themidpoint of the origin of replication and the start site of the agnogene are shown (the
nucleotide numbering starts at the midpoint of the origin of replication). The CY TCR (Yogo et al., 1990) is shown at the top of the ﬁgure and the consensus sequences identiﬁed for
various JCV lineages or sub-lineages are shown below in relation to the CY TCR, with similar nucleotides indicated by dashes and deletions identiﬁed by rectangles. Parallel sequences
connectedwith an oblique line in 2E/KB indicate a duplication.M and R in the Af2-b sequence indicate A or C and A or G, respectively. The sequences of lineages CY, Af1, Af2-a, B1-a and
B3-a and those of sub-lineages SC-b, -c, -d and -xwere identical and represented here by CY. The sequences of lineages EU-a, -b and -c and B1-cwere identical and represented here by
EU-a. The sequences of sub-lineagesMY-a and -bwere identical and represented here byMY-a. The sequences of sub-lineages SC-a and -ewere identical and represented here by SC-a.
120 Y. Yogo et al. / Virology 380 (2008) 118–123lineages (Fig. 2 and Table 1). (In lineage Af1, two of the four isolates
examined had rearrangements, both of which were classiﬁed as
sporadic; this classiﬁcationwas tentative because the rearrangements
may turn out to be common, if a larger number of isolates are
examined.) The features of the sporadic TCR rearrangements (Fig. 2
and Table 1) are summarized as follows.
1. Compared to the complicated rearrangements in PML-type TCRs
(Yogo and Sugimoto, 2001), all sporadic rearrangements showedFig. 2. TCR sequences carrying sporadic rearrangements. Sequences between the midpoint o
numbering starts at the midpoint of the origin of replication). The CY TCR (Yogo et al., 19
rearrangements are shown below in relation to the CY TCR, with similar nucleotides indicat
oblique lines indicate duplications. Lineages and sub-lineages are shown within parenthesesimple rearrangements (deletions or duplications of usually short
segments).
2. Deletions (n=21) occurred more frequently than duplications
(n=7).
3. The incidence of sporadic rearrangements was signiﬁcantly higher
in some lineages or sub-lineages (EU-c, Af1, MY-g, SC-b and -e) than
in others (Af2-b, B1-b1, MY-b, SC-f and 2E/KB) (Pb0.01 or Pb0.05)
(Table 1). However, for the small sample sizes (two to eight) in the
lineages or sub-lineages in which the incidence of sporadicf the origin of replication and the start site of the agnogene are shown (the nucleotide
90) is shown at the top of the ﬁgure and the TCR sequences of isolates with sporadic
ed by dashes and deletions identiﬁed by rectangles. Parallel sequences connected with
s.
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numbers of isolates is needed.
4. The same deletions or duplications sometimes occur in different
strains. Thus, a 13-bp duplication (location, nt 166–178) occurred in
strains N5 (lineage EU-a), SW-3 (EU-a) and strain LZ-12 (B1-a); a
10-bp deletion (nt 51–60) occurred in strains NG-3 (Af2-b) and ET-2
(Af2-b); and a 10-bp deletion (nt 53–62) occurred in strains GH-1
(Af1) and KB-32 (2E).
5. TCR changes identical to four of the six common rearrange-
ments were detected as sporadic rearrangements. Thus, the
sporadic TCR rearrangements (10-bp deletion spanning nt 53 to
62) found in isolates GH-1 (lineage Af1) and KB-32 (2E) were
identical with the common TCR rearrangement of sub-lineage
MY-f; the sporadic rearrangement (11-bp deletion spanning nt
106 to 116) found in isolate Sam-3 (EU-a) was identical with
the common TCR rearrangement of sub-lineage MY-f; the
sporadic rearrangements (2-bp deletions from nt 218 to 219)
in GH-4 (Af1) and MO-1 (B1-b1) were identical with the
common rearrangement in sub-lineages B1-b1, -b2 and -d; and
the sporadic rearrangement (5-bp deletion spanning nt 218 to
222) in CH-17 (SC-e) was identical to the common rearrange-
ment in sub-lineage SC-f.Discussion
We showed that isolates belonging to most lineages and sub-
lineages had archetypal TCRs, that is, identical, or almost identical,
with the CY TCR (Yogo et al., 1990), with a few nucleotide mismatches
but without any rearrangements (Fig. 1). This ﬁnding demonstrates
that the ancestral JCV had an archetypal TCR and that this
conﬁguration has essentially been conserved during the evolution of
JCV, providing support for the view that JCV strains carrying
archetypal TCRs, or those slightly deviating from it, circulate in the
human population (Yogo et al., 1990; Yogo and Sugimoto, 2001).
Additionally, we conﬁrmed that TCR rearrangements occurred in
several isolates belonging to various lineages and sub-lineages. We
classiﬁed these TCR rearrangements into two categories, sporadic
rearrangements found in rare isolates and common rearrangements
identiﬁed in all, or essentially all, isolates belonging to particular
lineages or sub-lineages. Interestingly, TCR changes identical with four
of the six common rearrangements occurred as sporadic rearrange-
ments. This observation suggests that sporadic and common rearran-
gements are not independent, but that the former may have been
transformed into the latter in the course of JCV evolution.
The question then arose as to how TCRs with common
rearrangements became the major TCR species, with the other
TCRs, including archetypal ones, eliminated from a population of
JCV. Common rearrangements might have provided a selective
advantage because of a higher growth ability. This possibility is
unlikely, however, since the same TCR rearrangements found as
common rearrangements in some lineages or sub-lineages occurred
as sporadic rearrangements (i.e., occurred only rarely) in others.
Therefore, an alternative explanation is needed for the shift from
sporadic to common TCR rearrangements.
We consider that the implications of the obtained results are
best interpreted on the basis of a close relationship between JCV
and human populations (Sugimoto et al., 1997; Yogo et al., 2004). As
for the origin and migration of modern humans, Ramachandran et al.
(2005) proposed a model of a serial founder effect with a single
origin in sub-Saharan Africa, and recent genetic studies have
provided substantial support for this model (Li et al., 2008;
Jakobsson et al., 2008). This model holds that in the course of
human migrations, new population was frequently formed by small
numbers of individuals. Since JCV co-migrated with human popula-
tions (Sugimoto et al., 1997; Stoner et al., 2000), JCV strains in theparental population would have been transmitted to the new
population. If it can be assumed that the number of individuals
who founded the new population was small, only a single strain may
have been transmitted to the new population. The transmitted JCV
strain may have carried a variant TCR with a sporadic rearrangement,
and may have evolved into a new lineage or sub-lineage with a
common rearrangement in the course of the expansion of the host
population.
Sporadic rearrangements were detected at higher rates in two
lineages (EU-c and Af1) and three sub-lineages (MY-g, SC-b and -e).
EU-c is the oldest lineage among the three lineages belonging to
super-lineage A (Sugimoto et al., 2002b), and Af1 is the only lineage
belonging to super-lineage C, possibly representing the ancient type of
JCV (Pavesi, 2003). It seems reasonable that sporadic rearrangements
accumulated in these old lineages. However, because of the small
sample sizes (two to eight) in the lineages or sub-lineages inwhich the
incidence of sporadic rearrangements was high (Table 1), further
analysis with larger numbers of isolates is needed.
The TCR rearrangements detected in complete JCV genomes
directly cloned from the urine of non-immunocompromised indivi-
duals (Figs. 1 and 2) were all simple rearrangements, presenting a
striking contrast to the complex TCR rearrangements detected in JCV
isolates from the brain and cerebrospinal ﬂuid of PML patients (Yogo
and Sugimoto, 2001). This is not surprising, because polyomavirus TCR
rearrangement may differently occur depending on tissues where
polyomaviruses replicate. Indeed, Gosert et al. (2008) recently
reported that BK polyomavirus (a human polyomavirus closely related
to JCV) undergoes TCR rearrangement more frequently in plasma than
in urine samples from renal transplant recipients. In addition, it
should be noted that JCV variants with PML-type TCRs persist only
within single hosts and never return to the human population (Yogo
and Sugimoto, 2001; this study).
In summary, we detected both common and sporadic TCR
rearrangements. The observation that several common rearrange-
ments in some lineages or sub-lineages also occurred as sporadic
rearrangements in other lineages or sub-lineages suggested that
sporadic rearrangements occasionally became common ones with the
evolution of JCV. We explained this ﬁnding based on the host-linked
evolution of JCV. In addition, this study has shown that the archetypal
conﬁguration of the JCV TCR has essentially been conserved in the
course of JCV evolution.
Materials and methods
Sequence data
Two hundred and ninety-eight TCR sequences of JCV were
derived from complete genomes directly cloned from the urine of
non-immunocompromised individuals. The origins of isolates,
including DDBJ/EMBL/GenBank accession numbers, are shown in
Supplementary Table 1. Numbers of isolates analyzed are shown in
Table 1 for each JCV lineage or sub-lineage. The classiﬁcation of the
isolates used in this study was conﬁrmed by a neighbor-joining
phylogenetic analysis based on complete coding sequences (Supple-
mentary Fig. 1).
Detection of rearrangements
TCR sequences were aligned using CLUSTAL W (Thompson et al.,
1994). Deletions and duplications were readily identiﬁed as gaps in
the aligned sequences.
Statistical analysis
Statistical analysis was performed using the chi-square test with a
Yates correction or with a Fisher exact test using the statistical
123Y. Yogo et al. / Virology 380 (2008) 118–123software package SPSS. The signiﬁcance level was set at 5%. All
statistical analyses were performed using numbers of strains, rather
than percentages.
Appendix A. Supplementary data
Supplementary data associatedwith this article can be found, in the
online version, at doi:10.1016/j.virol.2008.07.016.
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